Ballentine Partners’s Achaogen Inc AKAO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-19,823
Closed -$9K 407
2019
Q1
$9K Hold
19,823
﹤0.01% 330
2018
Q4
$24K Hold
19,823
﹤0.01% 341
2018
Q3
$79K Hold
19,823
﹤0.01% 356
2018
Q2
$172K Hold
19,823
0.01% 328
2018
Q1
$257K Hold
19,823
0.01% 279
2017
Q4
$213K Hold
19,823
0.01% 323
2017
Q3
$316K Hold
19,823
0.02% 256
2017
Q2
$394K Hold
19,823
0.03% 230
2017
Q1
$500K Hold
19,823
0.04% 125
2016
Q4
$258K Hold
19,823
0.02% 159
2016
Q3
$95K Hold
19,823
0.01% 192
2016
Q2
$75K Hold
19,823
0.01% 219
2016
Q1
$55K Hold
19,823
﹤0.01% 216
2015
Q4
$114K Buy
+19,823
New +$114K 0.01% 168

Other funds holding AKAO

Ballentine Partners's AKAO Position: Q2 2019 in Review

Ballentine Partners sold out of Achaogen Inc (AKAO) in Q2 2019, closing a stake of 19,823 shares — an estimated $9K sold.

Ballentine Partners first reported a position in AKAO in Q4 2015 and held it in 14 quarters. The position peaked at $500K in Q1 2017. 8 funds tracked by Wall St. Rank hold AKAO as of Q2 2019.

  • Ballentine Partners reported no remaining Achaogen Inc position as of Q2 2019 after selling out during the quarter.
  • Ballentine Partners sold 19,823 Achaogen Inc shares in Q2 2019, an estimated $9K.
  • Ballentine Partners first reported a position in Achaogen Inc in Q4 2015 and held it in 14 quarters.
  • Ballentine Partners's Achaogen Inc position peaked at $500K in Q1 2017.
  • 8 funds tracked by Wall St. Rank held Achaogen Inc as of Q2 2019.

Based on Ballentine Partners's 13F filing for Q2 2019, filed 25 Jul 2019.